Alivus Life Sciences Ltd.

A fair growth of 18.08% in the revenue at Rs. 5784.50 millions was reported in the June 2023 quarter as compared to Rs. 4898.70 millions during year-ago period.Profit saw a slight increase of 24.57%to Rs. 1354.50  millions from Rs. 1087.33 millions.OP of the company witnessed a marginal growth to 1950.12 millions from 1562.61 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202306	202206	% Var	202306	202206	% Var	202303	202203	% Var
Sales	5784.50	4898.70	18.08	5784.50	4898.70	18.08	21612.20	21232.14	1.79
Other Income	18.51	94.93	-80.50	18.51	94.93	-80.50	289.57	147.04	96.93
PBIDT	1950.12	1562.61	24.80	1950.12	1562.61	24.80	6712.50	6307.64	6.42
Interest	3.96	1.35	193.33	3.96	1.35	193.33	5.47	279.62	-98.04
PBDT	1946.16	1561.26	24.65	1946.16	1561.26	24.65	6707.03	6028.02	11.26
Depreciation	126.12	98.79	27.66	126.12	98.79	27.66	420.94	378.77	11.13
PBT	1820.04	1462.47	24.45	1820.04	1462.47	24.45	6286.09	5649.25	11.27
TAX	465.54	375.14	24.10	465.54	375.14	24.10	1616.48	1462.01	10.57
Deferred Tax	29.55	12.85	129.96	29.55	12.85	129.96	110.37	85.74	28.73
PAT	1354.50	1087.33	24.57	1354.50	1087.33	24.57	4669.61	4187.24	11.52
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	33.71	31.90	5.69	33.71	31.90	5.69	31.06	29.71	4.55